Looking to publish in Alzheimer s & Dementia Translational Research & Clinical Interventions? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowAlzheimer's & Dementia: Translational Research & Clinical Interventions (TRCI) is an open access journal that seeks to bridge drug discovery research and clinical studies for dementia and Alzheimer's disease. It publishes preclinical and clinical translational research, including disease biology, therapeutic development, observational and interventional human studies, precision medicine approaches, clinical trial design and outcomes, and related health economics focused on therapeutic development and treatment.
Looking to publish in Alzheimer s & Dementia Translational Research & Clinical Interventions? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Alzheimer s & Dementia Translational Research & Clinical Interventions accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Systematic Reviews
Meta-Analyses
Narrative Reviews
Research Articles
Short Reports
Letters To The Editor
Recent Publications
Association of Excessive Daytime Sleepiness With Long‐Term Incident Dementia: The Role of β‐Amyloid and White Matter Injury
Xiaowen Zhou, Guangshi Zhang, Qili Hu, Hanyu Shao, Tao Yang, Jie Wang, Xiaoniu Liang, Qianhua Zhao, Ding Ding
Peripheral immune markers in dementia: A systematic review and meta‐analysis of risk, severity, and pathological correlates
Ahmad A. Toubasi, Thuraya N. Al‐Sayegh
Virtual reality‐based cognitive‐motor training in middle‐aged adults at high Alzheimer's disease risk improves frontal cortex cerebral blood flow: A randomized controlled trial
Maayan Harel, Anat Leibovici, Nofar Itzhaki, Ramit Ravona‐Springer, Erin Moshier, Glen M. Doniger, Amihai Gottlieb, Yotam Bahat, Barbara B. Bendlin, Gabi Zeilig, Meir Plotnik, Michal Schneider Beeri, Abigail Livny
APOE ‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
Mai Othman, Eman Khedr, Shimaa Heikal, Mohamed H. Yousef, Gharib Fawi, Sara El Farrash, Samer Salama, Muhammad Abdelshafi, Nesma G. Elsheikh, Heba M. Tawfik, Hany I. Hassanin, Nourelhoda A. Haridy, Gellan K. Ahmed, Noha Abo Elftoh, Amna Ibrahim, Ahmed Qayaty, Eman M. Ali, Agsha Atputhavadivel, Samir Shamma, Noha A. Yousri, Mie Rizig, Mohamed Salama
Reframing Alzheimer's disease as a complex adaptive system: More than an amyloid beta–tau connection
Maurizio Giorelli
Frequently asked questions
How long does it take to publish?
Median submission to first decision is 19 days, median submission to acceptance is 104 days, and median acceptance to publication is 36 days.
Reformat to Alzheimer s & Dementia Translational Research & Clinical Interventions using Livewrite PremiumIs a cover letter required?
A submission letter should include the names, mailing addresses, phone and fax numbers, and e-mail addresses of 5-7 potential reviewers with appropriate expertise.
Reformat to Alzheimer s & Dementia Translational Research & Clinical Interventions using Livewrite PremiumWhat are the publication costs?
The journal operates an open access model and does not charge submission fees. APCs apply, with a 50% discount for ISTAART members and additional waivers and discounts for eligible authors in developing countries.
Reformat to Alzheimer s & Dementia Translational Research & Clinical Interventions using Livewrite Premium